Sign in
4/A

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-020056

Director acquired 1,231 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hernday Natasha Director 2024-07-19 Grant or award +1,231 6,231 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hernday Natasha Director 2024-07-19 Grant or award · Stock Option (Right to Buy) +4,111 4,111 D: show line 2 in the form
Loading xslF345X05/form4a-07242024_080702.xml…